SIGA Technologies, Inc (SIGA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

31 EAST 62ND STREET NEW YORK, NY 10065

Siga Technologies Inc. aims to discover, develop and commercialize novel anti-infectives, antibiotics and vaccines for serious infectious diseases, including products for use in defense against biological warfare agents such as smallpox. The company is developing a technology for the mucosal delivery of its vaccines.

Data as of 2020-06-27
Market Cap487.905 Million Shares Outstanding81.047 Million Avg 30-day Volume365.383 Thousand
P/E Ratio Dividend Yield EPS-0.25
Price/Sales25.811 Price cash flow ratio6.0 Price free cash flow ratio-33.6
Book Value1.09 Price to Tangible Book5.75 Alpha0.05
Short Interest Ratio % Short Interest to Float R-squared0.002108
BETA0.282813 52-week High/Low6.32 / 3.96 Stddev0.262778
View SEC Filings from SIGA instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 3 2 (0.13%)
13F Filers holding this stock: 92 25 (1.64%)
Aggregate 13F shares on 03/31/2020: 22.949 Million 11.946 Million
Aggregate 13F shares on 12/31/2019: 22.82 Million 12.199 Million
Percent change: 0.56% -2.07%
Funds creating new positions: 10 4
Funds Adding to an existing position: 31 9
Funds closing out their position: 16 4
Funds reducing their position: 27 10
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SIGA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SIGA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

120 Thousand total shares from 8 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TOWNSEND FRANCES F

  • Director
78,742 2020-06-19 0

SAVAS PAUL G

0 2020-06-16 5

MARSHALL JOSEPH W III

0 2020-06-16 2

ROSE ERIC A MD

0 2020-06-16 3

CONSTANCE THOMAS E

0 2020-06-16 2

ANTAL JAMES

0 2020-06-16 2

PLANSKY MICHAEL C.

0 2020-06-16 2

KANE JULIE

0 2020-06-16 3

DURNAN JAYMIE A

0 2020-06-16 2

KINDLER JEFFREY B

0 2020-06-11 1

FASMAN STEVEN L SVP & GENERAL COUNSEL

  • Officer
63,206 2020-04-09 0

LUCKSHIRE DANIEL J EXECUTIVE VP & CFO

224,943 2019-12-09 2

GOMEZ PHILLIP LOUIS III CHIEF EXECUTIVE OFFICER

475,782 2019-12-09 2

BAYER MICHAEL J

  • Director
0 2019-11-01 0

SLOTKIN JUDY S

  • Director
0 2019-09-11 0

ABRAMS ROBIN ELIZABETH GENERAL COUNSEL AND CAO

21,892 2019-07-31 1

HRUBY DENNIS E VP & CHIEF SCIENTIFIC OFFICER

147,465 2019-06-05 0

HAYNES WILLIAM J II EVP, GC AND SECRETARY

  • Officer
No longer subject to file 2018-04-03 0

STERN ANDREW L

77,865 2017-05-17 0

SLOVIN BRUCE

194,167 2017-05-17 0

MACANDREWS & FORBES INC.

PERELMAN RONALD O

MACANDREWS & FORBES LLC

  • Director
  • 10% Owner
24,156,358 2016-11-16 0

BEVINS WILLIAM C

  • Director
80,000 2014-05-15 0

WEINER MICHAEL MD

  • Director
15,000 2014-05-15 0

MACANDREWS & FORBES HOLDINGS INC.

PERELMAN RONALD O

MACANDREWS & FORBES LLC

STH PARTNERS, L.P.

  • Director
  • 10% Owner
13,105,838 2011-01-07 0

HAMMER SCOTT M

  • Director
0 2010-05-13 0

MJALLI ADNAN M M

  • Director
  • 10% Owner
0 2009-09-30 0

TRANSTECH PHARMA INC

  • 10% Owner
No longer subject to file 2009-09-30 0

OZ MEHMET C MD

  • Director
0 2009-05-13 0

DUGARY AYELET ACTING CHIEF FINANCIAL OFFICER

  • Officer
0 2009-03-05 0

KONATICH THOMAS N CHIEF FINANCIAL OFFICER

  • Officer
0 2008-04-01 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MARSHALL JOSEPH W III

2020-06-16 A 15,000 a 15,000 0.00 direct

KANE JULIE

2020-06-16 A 15,000 a 15,000 0.00 direct

DURNAN JAYMIE A

2020-06-16 A 15,000 a 15,000 0.00 direct

ROSE ERIC A MD

2020-06-16 A 15,000 a 15,000 0.00 direct

CONSTANCE THOMAS E

2020-06-16 A 15,000 a 15,000 0.00 direct

ANTAL JAMES

2020-06-16 A 15,000 a 15,000 0.00 direct

SAVAS PAUL G

2020-06-16 A 15,000 a 15,000 0.00 direct

PLANSKY MICHAEL C.

2020-06-16 A 15,000 a 15,000 0.00 direct

DURNAN JAYMIE A

2020-06-16 A 25,000 a 25,000 0.00 direct

PLANSKY MICHAEL C.

2020-05-21 M 15,000 a 45,000 45,000.00 direct

ANTAL JAMES

2020-05-21 M 15,000 a 145,875 145,875.00 direct

SAVAS PAUL G

2020-05-21 M 15,000 d 0 307,847.00 direct

KANE JULIE

2020-05-21 M 15,000 a 17,500 17,500.00 direct

MARSHALL JOSEPH W III

2020-05-21 M 15,000 d 0 157,769.00 direct

CONSTANCE THOMAS E

2020-05-21 M 15,000 a 312,806 312,806.00 direct

KINDLER JEFFREY B

2020-05-21 M 15,000 d 0 127,339.00 direct

SAVAS PAUL G

2020-05-21 M 15,000 a 307,847 307,847.00 direct

ROSE ERIC A MD

2020-05-21 M 15,000 d 0 1,053,593.00 direct

MARSHALL JOSEPH W III

2020-05-21 M 15,000 a 157,769 157,769.00 direct

PLANSKY MICHAEL C.

2020-05-21 M 15,000 d 0 45,000.00 direct

ANTAL JAMES

2020-05-21 M 15,000 d 0 145,875.00 direct

KINDLER JEFFREY B

2020-05-21 M 15,000 a 127,339 127,339.00 direct

KANE JULIE

2020-05-21 M 15,000 d 0 17,500.00 direct

ROSE ERIC A MD

2020-05-21 M 15,000 a 1,053,593 1,053,593.00 direct

CONSTANCE THOMAS E

2020-05-21 M 15,000 d 0 312,806.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments